Guardant Health, Inc. – NASDAQ:GH

Add to watchlist

$58.53

+28.09

+92.28%

Market closed

Open in about 17 hours

-2.03%

month

-2.03%

quarter

+8.64%

year

Market Cap	3.84B
Enterprise value	3.74B

P/E	-3.82
EV/Sales	8.32
EV/EBITDA	-6.08
Price/Sales	5.59
Price/Book	41.82
PEG ratio	0.06
EPS	-3.92

Revenue	603.72M
EBITDA	-487.05M
Income	-460.90M
Revenue Q/Q	30.90%
Revenue Y/Y	25.21%

Profit margin	-145.61%
Oper. margin	-121.1%
Gross margin	65.23%
EBIT margin	-121.1%
EBITDA margin	-80.68%

Get more financial ratios!

Every financial ratio you might need
10 years history
Forward ratios (Analysts estimates)

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Guardant Health, Inc. (NASDAQ:GH): Profit margin
Jun 2023	137.15M	-72.77M	-53.06%
Sep 2023	143.03M	-86.10M	-60.2%
Dec 2023	155.05M	-187.04M	-120.63%
Mar 2024	168.49M	-114.98M	-68.24%

Guardant Health Financials Estimate

Q Y

Guardant Health, Inc. (NASDAQ:GH): Analyst Estimates
Sep 2025	218.42M	-94.82M	-43.41%
Oct 2025	206.90M	-87.66M	-42.37%
Dec 2025	229.21M	-84.99M	-37.08%
Dec 2025	220.39M	-82.12M	-37.26%

Analysts Price target
Financials & Ratios estimates

Guardant Health, Inc. (NASDAQ:GH): Debt to assets
Jun 2023	1840017000	1.54B	84.09%
Sep 2023	1797231000	1.56B	87.3%
Dec 2023	1786421000	1.62B	91.12%
Mar 2024	1704598000	1.63B	95.99%

Guardant Health, Inc. (NASDAQ:GH): Cash Flow
Jun 2023	-94.01M	-241.12M	383.85M
Sep 2023	-77.79M	260.69M	3.80M
Dec 2023	-78.72M	663.45M	90.56M
Mar 2024	-30.28M	28.06M	-1.07M

Guardant Health alternative data

Guardant Health
Employees

Guardant Health, Inc. (NASDAQ:GH): Employee count
Sep 2023	1,793
Oct 2023	1,793
Nov 2023	1,793
Dec 2023	1,793
Jan 2024	1,793
Feb 2024	1,793
Mar 2024	1,768
Apr 2024	1,768
May 2024	1,768
Jun 2024	1,768
Jul 2024	1,768
Dec 2024	1,768

Guardant Health
Hedge Funds Holdings Q3 2022

86.26% -3.43%

of GH is owned by hedge funds

298 -13

hedge funds hold GH stock

88.02M -3.33M

shares is hold by hedge funds

GH hedge funds holdings changes

Guardant Health
Insider Trading

Guardant Health, Inc. (NASDAQ:GH): Insider trades (number of shares)
Period	Buy	Sel
Mar 2024	2187	100
Jun 2024	0	100
Nov 2024	0	18214
Dec 2024	0	2420

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	15 Dec 2024	SAIA JOHN G. officer: Chief Le..	Common Stock	1,020	N/A	N/A
Option	15 Dec 2024	SAIA JOHN G. officer: Chief Le..	Restricted Stock Units	1,020	N/A	N/A
Option	15 Dec 2024	POTTER MYRTLE S director director	Common Stock	69	N/A	N/A
Option	15 Dec 2024	POTTER MYRTLE S director director	Restricted Stock Units	69	N/A	N/A
Option	15 Dec 2024	KALIA KUMUD officer: Chief Information Officer officer: Chief Information Offi..	Common Stock	637	N/A	N/A
Option	15 Dec 2024	KALIA KUMUD officer: Chief Information Officer officer: Chief Information Offi..	Restricted Stock Units	637	N/A	N/A
Option	15 Dec 2024	FREEMAN CHRIS officer: Chief Commercial Officer officer: Chief Commercial Officer	Common Stock	1,402	N/A	N/A
Option	15 Dec 2024	FREEMAN CHRIS officer: Chief Commercial Officer officer: Chief Commercial Officer	Restricted Stock Units	1,402	N/A	N/A
Option	15 Dec 2024	EAGLE CRAIG officer: Chief Medical Officer officer: Chief Medical Officer	Common Stock	1,402	N/A	N/A
Option	15 Dec 2024	EAGLE CRAIG officer: Chief Medical Officer officer: Chief Medical Officer	Restricted Stock Units	1,402	N/A	N/A

GH insider trading transactions

Status	Patent	Filling date	Issue date
Grant	Grant Utility: Methods for 3' overhang repair Filling date: 23 Oct 2020 Issue date: 20 Sep 2022	23 Oct 2020	20 Sep 2022
Grant	Grant Utility: Systems and methods to detect rare mutations and copy number variation Filling date: 13 Oct 2020 Issue date: 20 Sep 2022	13 Oct 2020	20 Sep 2022
Grant	Grant Utility: Methods and systems for detecting genetic variants Filling date: 24 Aug 2021 Issue date: 6 Sep 2022	24 Aug 2021	6 Sep 2022
Grant	Grant Utility: Systems and methods to detect rare mutations and copy number variation Filling date: 26 Jun 2020 Issue date: 6 Sep 2022	26 Jun 2020	6 Sep 2022
Grant	Grant Utility: Methods of attaching adapters to sample nucleic acids Filling date: 13 Apr 2018 Issue date: 12 Jul 2022	13 Apr 2018	12 Jul 2022
Application	Application DETECTION AND TREATMENT OF DISEASE EXHIBITING DISEASE CELL HETEROGENEITY AND SYSTEMS AND METHODS FOR COMMUNICATING TEST RESULTS Filling date: 21 Mar 2022 Issue date: 7 Jul 2022	21 Mar 2022	7 Jul 2022
Application	Application SYSTEMS AND METHODS TO DETECT RARE MUTATIONS AND COPY NUMBER VARIATION Filling date: 16 Mar 2022 Issue date: 30 Jun 2022	16 Mar 2022	30 Jun 2022
Application	Application METHODS FOR ISOLATING CELL-FREE DNA Filling date: 29 Jul 2021 Issue date: 23 Jun 2022	29 Jul 2021	23 Jun 2022
Application	Application METHODS FOR EARLY DETECTION OF CANCER Filling date: 7 Mar 2022 Issue date: 16 Jun 2022	7 Mar 2022	16 Jun 2022
Grant	Grant Utility: Methods for detecting single nucleotide variants or indels by deep sequencing Filling date: 21 Oct 2021 Issue date: 14 Jun 2022	21 Oct 2021	14 Jun 2022

Guardant Health
Earnings Call Transcripts

Quarter	Transcript
Q3 2024 6 Nov 2024	Q3 2024 Earnings Call Transcript
Q2 2024 7 Aug 2024	Q2 2024 Earnings Call Transcript
Q1 2024 8 May 2024	Q1 2024 Earnings Call Transcript
Q4 2023 22 Feb 2024	Q4 2023 Earnings Call Transcript

GH earnings call transcripts

Guardant Health
Executives

Insider	Age	Compensation
Mr. John G. Saia (1973) Senior Vice President, Gen. Counsel & Corporation Sec.	52	$651,290
Mr. Michael J. Wiley (1976) Head of Corporation Affairs	49	$640,380
Dr. AmirAli Talasaz Ph.D. (1979) Co-Chief Executive Officer & Director	46	$289,720
Dr. Helmy Eltoukhy Ph.D. (1979) Co-Founder, Co-Chief Executive Officer & Chairman	46	$275,660

Guardant Health
Latest News

Friday, 20 December 2024
08:05	Meaningful Insights Biotech Analytics (MiBA) and Guardant Health Announce Strategic Partnership to Optimize Use of Biomarker Testing and Data Analytics to Improve Cancer Care	businesswire.com
Thursday, 19 December 2024
06:00	COTA and Guardant Health Partner to Advance Precision Oncology Research and Therapy Development with Real-World Clinicogenomic Data and AI Analytics	businesswire.com
Wednesday, 18 December 2024
08:05	Guardant Health Announces Collaboration With Boehringer Ingelheim to Develop Companion Diagnostic for Detection of Specific Mutations in Advanced Lung Cancer	businesswire.com
Monday, 9 December 2024
08:05	Guardant Health to Share New Research Demonstrating Value of Liquid Biopsy Tests, Real-world Data and AI Analytics in Tailoring Treatment Approaches for Breast Cancer at 2024 San Antonio Breast Cancer Symposium	businesswire.com
Wednesday, 4 December 2024
13:31	Guardant Health Stock Flashing Surefire ‘Buy' Signal	forbes.com
Monday, 25 November 2024
17:09	Federal Court Jury Issues Unanimous Verdict that Natera Engaged in False Advertising and Unfair Competition in Deliberate Attempt to Damage Guardant Health's Colorectal Cancer Test, Guardant Reveal™	prnewswire.com
Wednesday, 13 November 2024
17:05	Guardant Health Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	businesswire.com
Tuesday, 12 November 2024
11:55	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought	fool.com
Wednesday, 6 November 2024
21:53	Guardant Health, Inc. (GH) Q3 2024 Earnings Call Transcript	seekingalpha.com
21:00	Guardant Health (GH) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates	zacks.com
19:21	Guardant Health (GH) Reports Q3 Loss, Tops Revenue Estimates	zacks.com
Tuesday, 5 November 2024
10:20	Unveiling Guardant Health (GH) Q3 Outlook: Wall Street Estimates for Key Metrics	zacks.com
Wednesday, 30 October 2024
18:52	Why Guardant Health Stock Was the Picture of Health Today	fool.com
11:07	Will Guardant Health (GH) Report Negative Earnings Next Week? What You Should Know	zacks.com
09:30	Guardant Health Named to TIME's List of the Best Inventions of 2024	businesswire.com
Thursday, 24 October 2024
17:05	Roberto A. Mignone Joins Guardant Health Board of Directors	businesswire.com
Thursday, 17 October 2024
17:00	GameHost Announces Regular Monthly Dividend for October	accesswire.com
Tuesday, 15 October 2024
16:05	Guardant Health to Report Third Quarter 2024 Financial Results on November 6, 2024	businesswire.com
Friday, 13 September 2024
02:00	Guardant Health to Share Data at ESMO 2024 Further Demonstrating Strong Performance of Its Precision Oncology Technology in Multiple Advanced Tumor Types	businesswire.com
Tuesday, 27 August 2024
16:05	Guardant Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference	businesswire.com
Monday, 26 August 2024
10:40	Why Guardant Health Stock Just Crashed 10%	fool.com
Friday, 23 August 2024
10:45	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought	fool.com
Monday, 12 August 2024
11:45	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought	fool.com
Thursday, 8 August 2024
10:35	Guardant Health (GH) Recently Broke Out Above the 20-Day Moving Average	zacks.com
Wednesday, 7 August 2024
23:59	Guardant Health, Inc. (GH) Q2 2024 Earnings Call Transcript	seekingalpha.com
20:36	Guardant Health (GH) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates	zacks.com
19:50	Guardant Health (GH) Reports Q2 Loss, Tops Revenue Estimates	zacks.com
Tuesday, 6 August 2024
10:20	What Analyst Projections for Key Metrics Reveal About Guardant Health (GH) Q2 Earnings	zacks.com
Wednesday, 31 July 2024
09:45	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought	fool.com
Tuesday, 30 July 2024
08:14	Guardant Health's stock up after FDA approves its blood test for colon-cancer screening	marketwatch.com

Ideas & Opinions

Seeking Alpha 8 Aug 2025

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
Seeking Alpha 7 Jun 2025

I'm Still Bullish On Tempus AI
Seeking Alpha 1 May 2025

Guardant Health: Tailwinds Are Beginning To Impact The Financials
Seeking Alpha 31 Dec 2024

Natera: Poised For A Great Future But I'd Wait For A Pullback
Seeking Alpha 5 Apr 2024

Showcasing Seeking Alpha's March 2024 New Analysts
Seeking Alpha 10 Jul 2023

Guardant Health: A Growth Company Expanding Its Product Line Quickly
Seeking Alpha 29 Apr 2023

Exact Sciences: Ready To Benefit From Aging Millennials
Seeking Alpha 20 Apr 2023

Guardant Health: On Hold For Now
Seeking Alpha 2 Mar 2023

Guardant Health: Don't Expect Rapid Growth
Seeking Alpha 2 Mar 2023

Exact Sciences' Shift In Strategy: Targeting Positive Adjusted EBITDA

Frequently Asked Questions (FAQ)

What's the price of Guardant Health stock today?

One share of Guardant Health stock can currently be purchased for approximately $58.53.
When is Guardant Health's next earnings date?

Unfortunately, Guardant Health's (GH) next earnings date is currently unknown.
Does Guardant Health pay dividends?

No, Guardant Health does not pay dividends.
How much money does Guardant Health make?

Guardant Health has a market capitalization of 3.84B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 25.45% to 563.95M US dollars.
What is Guardant Health's stock symbol?

Guardant Health, Inc. is traded on the NASDAQ under the ticker symbol "GH".
What is Guardant Health's primary industry?

Company operates in the Healthcare sector and Medical - Diagnostics & Research industry.
How do i buy shares of Guardant Health?

Shares of Guardant Health can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Who are Guardant Health's key executives?
Guardant Health's management team includes the following people:
- Mr. John G. Saia Senior Vice President, Gen. Counsel & Corporation Sec.(age: 52, pay: $651,290)
- Mr. Michael J. Wiley Head of Corporation Affairs(age: 49, pay: $640,380)
- Dr. AmirAli Talasaz Ph.D. Co-Chief Executive Officer & Director(age: 46, pay: $289,720)
- Dr. Helmy Eltoukhy Ph.D. Co-Founder, Co-Chief Executive Officer & Chairman(age: 46, pay: $275,660)
Is Guardant Health founder-led company?

Yes, Guardant Health is a company led by its founder Dr. Helmy Eltoukhy Ph.D..
How many employees does Guardant Health have?

As Dec 2024, Guardant Health employs 1,768 workers.
When Guardant Health went public?

Guardant Health, Inc. is publicly traded company for more then 6 years since IPO on 4 Oct 2018.
What is Guardant Health's official website?

The official website for Guardant Health is guardanthealth.com.
Where are Guardant Health's headquarters?

Guardant Health is headquartered at 505 Penobscot Drive, Redwood City, CA.
How can i contact Guardant Health?

Guardant Health's mailing address is 505 Penobscot Drive, Redwood City, CA and company can be reached via phone at +855 6988887.

Guardant Health, Inc.

guardanthealth.com

Exchange:

NASDAQ

Full time employees:

1,768

Industry:

Medical - Diagnostics & Research

Sector:

Healthcare

Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a clinical-genomic liquid biopsy dataset of advanced cancer patients. It is also developing LUNAR-2 test for the early detection of colorectal cancer in asymptomatic individuals eligible; and GuardantConnect, an integrated software-based solution for clinical and biopharmaceutical customers seeking to connect patients tested with the Guardant360 assay with actionable alterations with potentially relevant clinical trials. In addition, the company offers Guardant Reveal Test for neoadjuvant and adjuvant treatment selection in early-stage cancer patients; Guardant360 tissue genotyping product; and Guardant-19 for use in the detection of the novel coronavirus. Further, it offers development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, and kits fulfillment related services to biopharmaceutical companies and medical institutions. The company was incorporated in 2011 and is headquartered in Redwood City, California.

+855 6988887

505 Penobscot Drive
Redwood City, CA 94063

CIK: 0001576280
ISIN: US40131M1099
CUSIP: 40131M109